Butovsky believes xenon has potential as an AD treatment. A Phase 1 clinical trial of xenon at BWH is recruiting healthy elderly volunteers to test safety and effects on immune cells. “I hope this ...
When we think about the immune system, we usually associate it with fighting infections. However, a study published in Science by the Champalimaud Foundation reveals a surprising new role.
Charles River Laboratories International, Inc. (NYSE: CRL) and Akron Bio ("Akron"), a leading supplier of critical materials and services for advanced therapies, today announced the integration of ...